2014 Walterhouse COG "A Phase II study of MLN8237, A Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias" ADVL0921

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/13 → 7/31/15

Funding

  • Children’s Hospital of Philadelphia
  • Millennium Pharmaceuticals, Inc.